We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Linguamatics Launches I2E OnDemand, the new Cloud Version of its Successful I2E Text Mining Platform

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Linguamatics, has announced the launch of its new “cloud” (online) version of the award winning I2E text mining platform. I2E OnDemand offers smaller companies the advanced, high performance text mining capabilities that big pharma companies have been using for years.

The new product features the powerful NLP based querying capabilities of the enterprise version of I2E. I2E OnDemand is being launched initially for use with MEDLINE because this massive, reputable data resource is the one most accessed for research by the pharmaceutical and biotech industries.

I2E OnDemand enables business-critical questions to be answered by extracting relevant facts and relationships from large document collections, in real-time, with relevant context. The online system will be provided with a range of different vocabularies, ontologies and a library of tested “off the shelf” NLP based queries, enabling customers to produce relevant, high quality results from day one.

With I2E OnDemand, all these capabilities become accessible to small to medium sized companies, who may not have the operational infrastructure in place to deploy such a platform in-house. To date, these companies have relied largely on classic search tools which do not apply NLP, severely limiting their ability to extract meaning and insights from the underlying data in a timely fashion. With I2E OnDemand, as with I2E, users are empowered to frame queries and synthesize knowledge in ways previously not possible.

“This is an exciting time for Linguamatics”, commented Roger Hale, Linguamatics COO and co-founder. “In what was another year of rapid customer growth for us, we saw significantly increased interest in our flagship I2E text mining platform in 2010. Now, not only do the majority of the world’s top pharma companies use the system in the pursuit of new biomedical discoveries and innovations, but small to medium sized organizations are also empowered to use this technology to make a dramatic impact on their speed to insight, decision making and hence competitive advantage.”